These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6447565)

  • 1. Suppression of immunoglobulin synthesis of systemic lupus erythematosus patients by concanavalin A-activated normal human spleen cell supernatants.
    Ilfeld DN; Krakauer RS
    Clin Immunol Immunopathol; 1980 Oct; 17(2):196-202. PubMed ID: 6447565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of in vitro polyclonal antibody synthesis in systemic lupus erythematosus by a soluble suppressor factor].
    Ilfeld D; Kuperman O; Krakauer RS
    Harefuah; 1980 Apr; 98(8):343-5. PubMed ID: 6449421
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens.
    Krakauer RS; Cathcart MK; Ilfeld DN
    Immunology; 1980 May; 40(1):53-60. PubMed ID: 6448220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid cell-derived lectin-like receptor molecules as immunoregulatory signals in immunodeficiency.
    Blaese RM; Muchmore AV; Tosato G
    Birth Defects Orig Artic Ser; 1983; 19(3):183-6. PubMed ID: 6228267
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function.
    Herscowitz HB; Sakane T; Steinberg AD; Green I
    J Immunol; 1980 Mar; 124(3):1403-10. PubMed ID: 6444652
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal suppressor-cell activity in systemic lupus erythematosus. A study on 26 cases.
    Gattringer C; Huber H; Michlmayr G; Braunsteiner H
    Immunobiology; 1982 Oct; 163(1):48-52. PubMed ID: 6217149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cells assayed by three different methods in patients with chronic active hepatitis and systemic lupus erythematosus.
    Coovadia HM; MacKay IR; d'Apice AJ
    Clin Immunol Immunopathol; 1981 Feb; 18(2):268-75. PubMed ID: 6451342
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrocortisone reverses the suppression of immunoglobulin synthesis by concanavalin A-activated spleen cell supernatants.
    Ilfeld D; Krakauer RS
    Clin Exp Immunol; 1982 Apr; 48(1):244-8. PubMed ID: 7200840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function.
    Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
    Scand J Immunol; 1979; 10(3):213-21. PubMed ID: 160612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.
    Theofilopoulos AN; Shawler DL; Eisenberg RA; Dixon FJ
    J Exp Med; 1980 Feb; 151(2):446-66. PubMed ID: 6444324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation.
    Korsmeyer SJ; Elfenbein GJ; Goldman CK; Marshall SL; Santos GW; Waldmann TA
    Transplantation; 1982 Feb; 33(2):184-90. PubMed ID: 6277055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial alterations of immunoregulation in systemic lupus erythematosus.
    Spencer-Green G; Adams LE; Hurtubise P; Kravatz G; Hess EV
    J Rheumatol; 1985 Jun; 12(3):498-503. PubMed ID: 2931520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of immunoglobulin synthesis by monocytes in health and in patients with systemic lupus erythematosus.
    Laughter AH; Lidsky MD; Twomey JJ
    Clin Immunol Immunopathol; 1979 Dec; 14(4):435-40. PubMed ID: 315849
    [No Abstract]   [Full Text] [Related]  

  • 14. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cell function defect in idiopathic systemic lupus erythematosus.
    Krakauer RS; Clough JD; Frank S; Sundeen JT
    Clin Immunol Immunopathol; 1979 Nov; 14(3):327-33. PubMed ID: 159148
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cells.
    Tsokos GC; Balow JE
    Clin Immunol Immunopathol; 1983 Feb; 26(2):267-76. PubMed ID: 6223747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
    Tsokos GC; Balow JE
    J Clin Lab Immunol; 1982 Jun; 8(2):83-90. PubMed ID: 6213778
    [No Abstract]   [Full Text] [Related]  

  • 18. [T-suppressor functional activity in systemic lupus erythematosus and chronic glomerulonephritis].
    Gordovskaia NB; Denisov VN; Krasnova TN
    Ter Arkh; 1982; 54(7):29-32. PubMed ID: 6215736
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.